Riyaz Bashir, TCT 2022: The Bashir endovascular catheter in patients with acute intermediate risk pulmonary embolism, the RESCUE study
The RESCUE study examined the Bashir endovascular catheter in patients with acute intermediate risk pulmonary embolism (PE). In this touchCARDIO interview, we speak with Dr Riyaz Bashir (Temple University Hospital, Philadelphia, PA, USA) to discuss the RESCUE study and future plans.
The abstract entitled ‘A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.
Questions:
- What were the aims, design and eligibility criteria of the RESCUE study? (0:23)
- What were the efficacy and safety findings of the study? (2:06)
- What questions remain unanswered regarding the use of this catheter, and what further studies are planned? (3:17)
Disclosures: Riyaz Bashir is on the advisory board and speaker’s bureau for Thrombolex Inc. and a consultant for the company. He has received honorarium and grant/research support from Thrombolex Inc. and is a major stock shareholder.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of TCT 2022
Access more content on Devices here
